Terns Pharmaceuticals, Inc.
Ticker: TERN
| Insider | Title |
|---|---|
| Advisors Iii Ltd Orbimed | Director, 10% or greater ownership |
| Advisors Llc Orbimed | Director, 10% or greater ownership |
| Amy L. Burroughs | Chief Executive Officer, Director |
| Ann Elizabeth Taylor | Director |
| Aqua Ltd Lav | 10% or greater ownership |
| Asia Gp Iii, L.p. Orbimed | Director, 10% or greater ownership |
| Biosciences Fund V, L.p. Lav | 10% or greater ownership |
| Capital Fund Viii, L.p. Vivo | 10% or greater ownership |
| Capital Gp Vii Llc Orbimed | Director, 10% or greater ownership |
| Capital Surplus Fund Viii, L.p. Vivo | 10% or greater ownership |
| Capital Viii, Llc Vivo | 10% or greater ownership |
| Carl L Gordon | Director, 10% or greater ownership |
| David A Fellows | Director |
| Emil Kuriakose | Chief Medical Officer |
| Erin Quirk | President, Head of RD |
| Genesis Gp Llc Orbimed | Director, 10% or greater ownership |
| Hongbo Lu | Director |
| Jeffrey B Kindler | Director |
| Jill M. Quigley | Director |
| Kerry Strong Russell | Chief Medical Officer |
| Mark J. Vignola | Chief Financial Officer |
| Melita Sun Jung | Chief Business Officer |
| Opportunity Fund Holdings, L.p. Vivo | 10% or greater ownership |
| Opportunity, Llc Vivo | 10% or greater ownership |
| Radhika Tripuraneni | Director |
| Resources Holdings Ltd Hopewell | 10% or greater ownership |
| Senthil Vel Sundaram | Chief Executive Officer, Director |
| Seokho Bryan Yoon | COO and General Counsel |
| Spring Venture Ltd Oriental | 10% or greater ownership |